» Articles » PMID: 33811364

Vaccines and Allergic Reactions: The Past, the Current COVID-19 Pandemic, and Future Perspectives

Abstract

Vaccines are essential public health tools with a favorable safety profile and prophylactic effectiveness that have historically played significant roles in reducing infectious disease burden in populations, when the majority of individuals are vaccinated. The COVID-19 vaccines are expected to have similar positive impacts on health across the globe. While serious allergic reactions to vaccines are rare, their underlying mechanisms and implications for clinical management should be considered to provide individuals with the safest care possible. In this review, we provide an overview of different types of allergic adverse reactions that can potentially occur after vaccination and individual vaccine components capable of causing the allergic adverse reactions. We present the incidence of allergic adverse reactions during clinical studies and through post-authorization and post-marketing surveillance and provide plausible causes of these reactions based on potential allergenic components present in several common vaccines. Additionally, we review implications for individual diagnosis and management and vaccine manufacturing overall. Finally, we suggest areas for future research.

Citing Articles

Sex, Age, and Previous Herpes Zoster Infection Role on Adverse Events Following Immunization with Adjuvanted Recombinant Vaccine.

Costantino M, Giudice V, Moccia G, Ragozzino M, Calabrese S, Caiazzo F Pathogens. 2025; 14(2).

PMID: 40005570 PMC: 11858321. DOI: 10.3390/pathogens14020195.


Unravelling the complexity of CARPA: a review of emerging advancements in therapeutic strategies.

Saxena S, Sharma S, Kumar G, Thakur S Arch Dermatol Res. 2025; 317(1):439.

PMID: 39971823 DOI: 10.1007/s00403-025-03971-z.


Using the diffusion of innovations theory to understand factors associated with COVID-19 vaccination among tobacco users.

DSouza G, Yingst J, Krebs N, Bordner C, Allen S, Calo W PLoS One. 2024; 19(12):e0309780.

PMID: 39666781 PMC: 11637259. DOI: 10.1371/journal.pone.0309780.


Immunization-related complex regional pain syndrome: A systematic review of case reports.

Copenhaver W, Goodwin B, Simonetti A, Shah K, Averell N, Lo D PCN Rep. 2024; 3(4):e70041.

PMID: 39664886 PMC: 11631839. DOI: 10.1002/pcn5.70041.


Impact of Comorbidities and Skin Diseases on Post-Vaccination Reactions: A Study on COVID-19 Vaccinations in Poland.

Jeskowiak-Kossakowska I, Nowotarska P, Grosman-Dziewiszek P, Szelag A, Wiatrak B J Clin Med. 2024; 13(20).

PMID: 39458123 PMC: 11508506. DOI: 10.3390/jcm13206173.


References
1.
Freitas D, Moura E, Araujo G, Cardoso A, Scheidt P, Ferraz E . Investigation of an outbreak of hypersensitivity-type reactions during the 2004 national measles-mumps-rubella vaccination campaign in Brazil. Vaccine. 2012; 31(6):950-4. DOI: 10.1016/j.vaccine.2012.11.095. View

2.
Fishbein D, Yenne K, Dreesen D, Teplis C, Mehta N, Briggs D . Risk factors for systemic hypersensitivity reactions after booster vaccinations with human diploid cell rabies vaccine: a nationwide prospective study. Vaccine. 1993; 11(14):1390-4. DOI: 10.1016/0264-410x(93)90167-v. View

3.
Klimek L, Jutel M, Akdis C, Bousquet J, Akdis M, Torres M . ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines - An EAACI-ARIA Position Paper. Allergy. 2020; 76(6):1624-1628. DOI: 10.1111/all.14726. View

4.
Bruusgaard-Mouritsen M, Johansen J, Garvey L . Clinical manifestations and impact on daily life of allergy to polyethylene glycol (PEG) in ten patients. Clin Exp Allergy. 2021; 51(3):463-470. DOI: 10.1111/cea.13822. View

5.
Shimabukuro T . Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine - United States, December 21, 2020-January 10, 2021. Am J Transplant. 2021; 21(3):1326-1331. PMC: 8013433. DOI: 10.1111/ajt.16517. View